OTLK
Outlook Therapeutics·NASDAQ
--
--(--)
--
--(--)
OTLK Filings
Filing Date
Form Description
Form Type
2026-02-05
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-02-05 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-01-26
Form ARS - Annual Report to Security Holders
2026-01-26 ·
Form ARS - Annual Report to Security Holders
2026-01-26
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Key Events
2026-01-26 · Key Events
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
2026-01-26
Form DEF 14A - Other definitive proxy statements
Key Events
2026-01-26 · Key Events
Form DEF 14A - Other definitive proxy statements
2026-01-02
Form 8-K - Current report
Key Events
2026-01-02 · Key Events
Form 8-K - Current report
2025-12-19
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Financials
2025-12-19 · Financials
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025-12-19
Form 8-K - Current report
Key Events
2025-12-19 · Key Events
Form 8-K - Current report
2025-11-13
Form 8-K - Current report
Key Events
2025-11-13 · Key Events
Form 8-K - Current report
2025-11-03
Form 8-K - Current report
Key Events
2025-11-03 · Key Events
Form 8-K - Current report
2025-10-21
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-10-21 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
